DIA Bioventure Day

Is the current Bioventure paradigm delivering return for patients and investors? This is the key question to be addressed by stakeholders from the funding, and from the innovating side.

Volver a Agenda

Welcome remarks

Speaker(s)

Holger G. Adelmann

DIA, Switzerland

Senior Vice President and Managing Director

Kerry Sharp

Scottish Investment Bank, United Kingdom

Head